| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC | 401 W 15TH ST STE 520 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 001 | 2 | 11/1/2023 | SUPPLEMENT FOR EXPANSION | $0 |
| 2024 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC | 401 W 15TH ST STE 520 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 000 | 2 | 11/1/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $414,246 ) |
| 2023 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 002 | 2 | 8/14/2023 | SUPPLEMENT FOR EXPANSION | $182,837 |
| 2023 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 000 | 2 | 11/1/2022 | NON-COMPETING CONTINUATION | $231,409 |
| 2023 | 2023 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 001 | 2 | 1/17/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $230,834 ) |
| 2022 | 2022 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 000 | 1 | 11/11/2021 | NEW | $230,834 |
| 2022 | 2022 | CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM, INC | 401 W 15TH ST STE 800 | AUSTIN | TX | 78701 | TRAVIS | USA | Food and Drug Administration Research | 001 | 1 | 12/16/2021 | NEW | $0 |
|
|